The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 11110 malaria professionals are enjoying the free benefits of MalariaWorld today

Scientific Articles

Open Access | Commentary: Knowlesi malaria in Vietnam

December 5, 2009 - 16:58 -- Ingeborg van Schayk
Tags: 
Author(s): 
Janet Cox-Singh
Reference: 
Malaria Journal 2009, 8:269 (26 November 2009)

However, there are many settings where knowlesi transmission to humans would be expected but is not found. A recent report on the Ra-glai population of southern central Vietnam is taken as an example to help explain why this may be so.

Country: 
Medical Condition: 

Characterization and antigenicity of the promising vaccine candidate Plasmodium vivax 34 kDa rhoptry antigen (Pv34)

December 5, 2009 - 16:25 -- Kabogo Ndegwa
Author(s): 
Alvaro Mongui, Diana I. Angel, Gina Gallego, Claudia Reyes, Paola Martinez, Felipe Guhl, Manuel A. Patarroyo
Reference: 
Vaccine, Volume 28, Issue 2, 11 December 2009, Pages 415-421, doi:10.1016/j.vaccine.2009.10.034

This study describes the identification of the Plasmodium vivax rhoptry antigen Pv34 whose sequence was obtained based on homology comparison with the Plasmodium falciparum Pf34.

Medical Condition: 

Correspondence: Diagnostic importance of headache as a key symptom in suspecting malaria in adult returning travelers

December 5, 2009 - 16:21 -- Patrick Sampao
Author(s): 
Francisco M. Pherez, Burke A. Cunha
Reference: 
Travel Medicine and Infectious Disease, Volume 7, Issue 6, November 2009, Pages 383-384. doi:10.1016/j.tmaid.2009.09.004

No abstract available.

Person: 
Medical Condition: 
Medical Treatment: 

Evaluation of the safety and immunogenicity of Plasmodium falciparum apical membrane antigen 1, merozoite surface protein 1 or RTS, S vaccines with adjuvant system AS02A administered alone or concurrently in rhesus monkeys

December 5, 2009 - 16:19 -- Kabogo Ndegwa
Author(s): 
S. Pichyangkul, P. Tongtawe, U. Kum-Arb, K. Yongvanitchit, M. Gettayacamin, M.R. Hollingdale, A. Limsalakpetch, V.A. Stewart, D.E. Lanar, S. Dutta, E. Angov, L.A Ware, E.S. Bergmann-Leitner, B. House, G. Voss, M.C. Dubois, J.D. Cohen, M.M. Fukuda, D.G. Heppner, R.S. Miller.
Reference: 
Vaccine, Volume 28, Issue 2, 11 December 2009, Pages 452-462, doi:10.1016/j.vaccine.2009.10.022

In an effort to broaden the immune response induced by the RTS,S/AS02A,vaccine, we have evaluated the immunogenicity of the RTS,S antigen when combined with MSP142 and with AMA1, antigens derived from the asexual blood stage.

Technology: 
Medical Condition: 

Effectiveness of malaria chemoprophylaxis against Plasmodium falciparum infection in UK travellers: Retrospective observational data

December 4, 2009 - 16:07 -- Patrick Sampao
Author(s): 
Jane N. Zuckerman, Anthony J. Batty, Michael E. Jones.
Reference: 
Travel Medicine and Infectious Disease, Volume 7, Issue 6, November 2009, Pages 329-336, doi:10.1016/j.tmaid.2009.10.002.

Further work is required to ascertain whether ease of use and compliance may be important factors in the outcomes associated with malariachemoprophylaxis.

Person: 
Country: 
Medical Condition: 
Medical Treatment: 

Anopheles mosquito transmission of brain tumor

December 4, 2009 - 16:00 -- Patrick Sampao
Author(s): 
Steven Lehrer
Reference: 
Medical Hypotheses, Volume 74, Issue 1, January 2010, Pages 167-168, doi:10.1016/j.mehy.2009.07.005 R

If a mosquito-transmitted brain tumor virus could be identified, development of a brain tumor vaccine might be possible.

Medical Condition: 

Comparing human T cell and NK cell responses in viral-based malaria vaccine trials

December 3, 2009 - 12:17 -- Patrick Sampao
Tags: 
Author(s): 
Tamara K. Berthoud, Helen Fletcher, David Porter, Fiona Thompson, Adrian V.S. Hill, Stephen M. Todryk
Reference: 
Vaccine, Volume 28, Issue 1, 10 December 2009, Pages 21-27

In conclusion, measuring antigen-specific T cells is more meaningful than NK cells in these vaccination regimens.

Medical Treatment: 

Household risk factors for clinical malaria in a semi-urban area of Burkina Faso: a case–control study

December 3, 2009 - 12:13 -- Patrick Sampao
Author(s): 
S. Yamamotoa, V.R. Louisa, A. Siéb and R. Sauerborna
Reference: 
Transactions of the Royal Society of Tropical Medicine and Hygiene, Volume 104, Issue 1, January 2010, Pages 61-65, doi:10.1016/j.trstmh.2009.07.003.

This study examined the effect of different housing and household characteristics on malaria risk among 98 case and 185 control children in the semi-urban area of Nouna, Burkina Faso.

Technology: 
Country: 
Medical Condition: 

Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection.

December 3, 2009 - 12:11 -- Kabogo Ndegwa
Author(s): 
Manuel A. Giraldo, Gabriela Arevalo-Pinzon, Jose Rojas-Caraballo, Alvaro Mongui, Raul Rodriguez, Manuel A. Patarroyo
Reference: 
Vaccine, Volume 28, Issue 1, 10 December 2009, Pages 7-13, doi:10.1016/j.vaccine.2009.09.046.

In this study, the P. vivax merozoite surface protein 10 (MSP-10) was expressed as a recombinant protein in Escherichia coli and purified by affinity chromatography. 

Medical Treatment: 

Pages

Subscribe to Scientific Articles